FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Regentis Biomaterials Ltd.: xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

One fact, its scope and the complete path back to the official record.

Period: as of 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/072a46a6-e3d6-41bc-a76e-8d4e9df8540f

Reported value

$1.240M{"amount": 1240000, "currency": "USD"}
Entity
Regentis Biomaterials Ltd.
Metric
xbrl:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
Period
as of 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-26-019917 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T18:55:19.402397+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.